ClinicalTrials.govpublic full text
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
non-small cell lung cancer, adjuvant therapy, immune checkpoint inhibitors, adjuvant immunotherapy, circulating tumor dna, immune checkpoint inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811484
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.